NASDAQ:FBIO - Fortress Biotech News Headlines

$1.58
-0.18 (-10.23 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
$1.66
Now: $1.58
$1.76
50-Day Range
$1.27
MA: $1.45
$1.81
52-Week Range
$0.49
Now: $1.58
$2.59
Volume286,188 shs
Average Volume277,321 shs
Market Capitalization$109.08 million
P/E RatioN/A
Dividend YieldN/A
Beta2.48

Headlines

Fortress Biotech (NASDAQ FBIO) News Headlines

Source:
DateHeadline
Mustang Bio and St. Jude Children’s Research Hospital announce MB-107 lentiviral gene therapy for X-linked Severe Combined Immunodeficiency (XSCID) granted regenerative medicine advanced therapy (RMAT) designation from FDAMustang Bio and St. Jude Children’s Research Hospital announce MB-107 lentiviral gene therapy for X-linked Severe Combined Immunodeficiency (XSCID) granted regenerative medicine advanced therapy (RMAT) designation from FDA
finance.yahoo.com - August 22 at 8:05 AM
Fortress Biotech Announces Appointment of Kevin L. Lorenz, J.D., to Board of DirectorsFortress Biotech Announces Appointment of Kevin L. Lorenz, J.D., to Board of Directors
finance.yahoo.com - August 19 at 10:07 AM
Fortress Biotech (NASDAQ:FBIO) Sees Significant Growth in Short InterestFortress Biotech (NASDAQ:FBIO) Sees Significant Growth in Short Interest
www.americanbankingnews.com - August 13 at 1:25 PM
Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 in HER2-Positive Breast Cancer with Brain MetastasesMustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 in HER2-Positive Breast Cancer with Brain Metastases
finance.yahoo.com - August 13 at 10:56 AM
Fortress Biotech (NASDAQ:FBIO) Releases Quarterly  Earnings Results, Beats Estimates By $0.22 EPSFortress Biotech (NASDAQ:FBIO) Releases Quarterly Earnings Results, Beats Estimates By $0.22 EPS
www.americanbankingnews.com - August 10 at 1:05 PM
$7.51 Million in Sales Expected for Fortress Biotech (NASDAQ:FBIO) This Quarter$7.51 Million in Sales Expected for Fortress Biotech (NASDAQ:FBIO) This Quarter
www.americanbankingnews.com - August 8 at 3:52 AM
Zacks: Analysts Expect Fortress Biotech (NASDAQ:FBIO) Will Post Earnings of -$0.46 Per ShareZacks: Analysts Expect Fortress Biotech (NASDAQ:FBIO) Will Post Earnings of -$0.46 Per Share
www.americanbankingnews.com - August 6 at 4:07 PM
FDA Clears IND for Mustang Bio’s MB-102 (CD123 CAR T)FDA Clears IND for Mustang Bio’s MB-102 (CD123 CAR T)
finance.yahoo.com - August 5 at 10:08 AM
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid LeukemiaMustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid Leukemia
finance.yahoo.com - July 24 at 10:15 AM
Checkpoint Therapeutics Added to Russell 2000® IndexCheckpoint Therapeutics Added to Russell 2000® Index
finance.yahoo.com - July 1 at 9:25 AM
Mustang Bio and St. Jude Children’s Research Hospital to Participate in Panel Discussion at Boston CEO 2019Mustang Bio and St. Jude Children’s Research Hospital to Participate in Panel Discussion at Boston CEO 2019
finance.yahoo.com - May 23 at 10:28 AM
Will Fortress Biotech to Surge Higher?Will Fortress Biotech to Surge Higher?
finance.yahoo.com - May 17 at 10:29 AM
Mustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant GliomaMustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma
finance.yahoo.com - May 16 at 8:07 AM
Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019
finance.yahoo.com - May 13 at 9:52 AM
Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate HighlightsFortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
www.globenewswire.com - May 10 at 10:43 AM
Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate HighlightsCheckpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
finance.yahoo.com - May 9 at 5:07 PM
Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 ProteinMustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein
finance.yahoo.com - May 8 at 10:32 AM
Mustang Bio Announces Full Exercise of OptionMustang Bio Announces Full Exercise of Option
finance.yahoo.com - May 8 at 10:32 AM
What Kind Of Shareholders Own Fortress Biotech, Inc. (NASDAQ:FBIO)?What Kind Of Shareholders Own Fortress Biotech, Inc. (NASDAQ:FBIO)?
finance.yahoo.com - April 29 at 10:00 AM
Mustang Set To Become A Mini-Sarepta On Bubble Boy Miracle Cure; Fortress Along For The RideMustang Set To Become A Mini-Sarepta On Bubble Boy Miracle Cure; Fortress Along For The Ride
seekingalpha.com - April 24 at 10:18 AM
Mustang Bio Gallops Higher On Positive Gene Therapy Results For Deadly Bubble Boy DiseaseMustang Bio Gallops Higher On Positive Gene Therapy Results For Deadly 'Bubble Boy Disease'
www.benzinga.com - April 18 at 11:15 AM
The Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds PortfolioThe Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds Portfolio
finance.yahoo.com - April 18 at 11:15 AM
Fortress Biotech Inc.Fortress Biotech Inc.
www.barrons.com - April 18 at 11:15 AM
Mustang Bio rally lifts Fortress Bio, up 62% premarketMustang Bio rally lifts Fortress Bio, up 62% premarket
seekingalpha.com - April 18 at 11:15 AM
St. Jude Children’s Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of MedicineSt. Jude Children’s Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine
finance.yahoo.com - April 18 at 11:15 AM
Mustang Bio Soars 485% After Its Novel Gene Therapy Cured ‘Bubble Boys’Mustang Bio Soars 485% After Its Novel Gene Therapy Cured ‘Bubble Boys’
finance.yahoo.com - April 18 at 11:15 AM
Mustang Bio to Present at the World Orphan Drug Congress USA 2019Mustang Bio to Present at the World Orphan Drug Congress USA 2019
finance.yahoo.com - April 9 at 11:52 AM
Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology FinanceMustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance
finance.yahoo.com - April 1 at 12:07 PM
Fortress Biotech, Inc. Estimate MomentumFortress Biotech, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 4:57 PM
Mustang Bio Reports Full-Year 2018 Financial Results and Recent Corporate HighlightsMustang Bio Reports Full-Year 2018 Financial Results and Recent Corporate Highlights
finance.yahoo.com - March 18 at 10:13 AM
Fortress Biotech Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Corporate HighlightsFortress Biotech Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Corporate Highlights
finance.yahoo.com - March 18 at 10:13 AM
Fortress Biotech to Present at the 31st Annual ROTH Conference - NasdaqFortress Biotech to Present at the 31st Annual ROTH Conference - Nasdaq
www.nasdaq.com - March 15 at 4:55 PM
All You Need to Know About Fortress Biotech (FBIO) Rating Upgrade to Strong BuyAll You Need to Know About Fortress Biotech (FBIO) Rating Upgrade to Strong Buy
finance.yahoo.com - March 14 at 5:08 PM
Fortress Biotech to Present at the 31st Annual ROTH ConferenceFortress Biotech to Present at the 31st Annual ROTH Conference
www.marketwatch.com - March 14 at 11:24 AM
Mustang Bio to Present at Oppenheimer’s 29th Annual Healthcare ConferenceMustang Bio to Present at Oppenheimer’s 29th Annual Healthcare Conference
finance.yahoo.com - March 13 at 10:03 AM
Sarepta (SRPT) Jumps: Stock Rises 8.3%Sarepta (SRPT) Jumps: Stock Rises 8.3%
finance.yahoo.com - February 28 at 10:58 AM
Fortress Biotech IncFortress Biotech Inc
www.bloomberg.com - February 23 at 10:27 AM
Mustang Bio and Nationwide Children’s Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma MultiformeMustang Bio and Nationwide Children’s Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme
finance.yahoo.com - February 20 at 11:25 AM
Fortress Bio completes divestment of National Holdings shares - Seeking AlphaFortress Bio completes divestment of National Holdings shares - Seeking Alpha
seekingalpha.com - February 14 at 10:37 AM
Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Corporation - GlobeNewswireFortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Corporation - GlobeNewswire
globenewswire.com - February 14 at 10:37 AM
Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings CorporationFortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Corporation
finance.yahoo.com - February 12 at 10:55 AM
Evolus leads healthcare gainers; Fortress Biotech and Check-Cap among losers - Seeking AlphaEvolus leads healthcare gainers; Fortress Biotech and Check-Cap among losers - Seeking Alpha
seekingalpha.com - February 6 at 4:51 PM
Fortress BioTech, Late Stage Development Progress and Caelum Partnership with AlexionFortress BioTech, Late Stage Development Progress and Caelum Partnership with Alexion
finance.yahoo.com - February 1 at 10:23 AM
Alexion Pharmaceuticals: In The News And Moving HigherAlexion Pharmaceuticals: In The News And Moving Higher
seekingalpha.com - January 31 at 4:59 PM
4 Biotech Stocks Making Moves On Thursday (1/31/19)4 Biotech Stocks Making Moves On Thursday (1/31/19)
finance.yahoo.com - January 31 at 10:24 AM
ATXI: How Much Are CVRs Worth?ATXI: How Much Are CVRs Worth?
finance.yahoo.com - January 28 at 10:32 AM
Have Insiders Been Selling Fortress Biotech, Inc. (NASDAQ:FBIO) Shares?Have Insiders Been Selling Fortress Biotech, Inc. (NASDAQ:FBIO) Shares?
finance.yahoo.com - January 27 at 9:30 AM
Friday Sector Laggards: Drugs, Biotechnology StocksFriday Sector Laggards: Drugs, Biotechnology Stocks
www.nasdaq.com - December 22 at 9:14 AM
2 Ways To Play Avenue, IV Tramadol As Fortress Sheds National Holdings - Seeking Alpha2 Ways To Play Avenue, IV Tramadol As Fortress Sheds National Holdings - Seeking Alpha
seekingalpha.com - December 21 at 4:45 PM
Aduro BioTech and PolarityTE among healthcare gainers; Biocept and Fortress Biotech among losers - Seeking AlphaAduro BioTech and PolarityTE among healthcare gainers; Biocept and Fortress Biotech among losers - Seeking Alpha
seekingalpha.com - December 21 at 4:45 PM
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel